Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Advances in Complementary & Alternative medicine

Complementary Treatment of Mood Disturbances in Terminally Ill Oncological Patients with the Aphanizomenon Flos Aquae Extract Klamin®

Submission: January 02, 2018; Published: February 22, 2018

DOI: 10.31031/ACAM.2018.01.000515

ISSN: 2637-7802
Volume1 Issue3

Abstract

Klamin® is a proprietary extract of the microalgae Aphanizomenon flos aquae, which concentrates both the phenylethylamine (PEA) naturally contained in the microalgae, and microalgal molecules, such as AFA-phycocyanins and mycosporine-like amino acids (MAAs), which act as physiological MAO-B inhibtors, thus allowing PEA to reach the brain and explete its numerous neuro-modulating activities. Based on this premise, and on previous studies showing the mood enhancing activity of the extract, we tested its ability to improve the very difficult condition of terminal cancer patients, with special reference to their levels of depression, anxiety and fatigue. The results obtained were positive, in spite of the extreme condition of the patients, with significant improvement of their levels of depression and anxiety, and a lesser but still relevant improvement of their level of fatigue. This preliminary study warrants the need for further research on this very relevant subject.

Get access to the full text of this article


About Crimson

We at Crimson Publishing are a group of people with a combined passion for science and research, who wants to bring to the world a unified platform where all scientific know-how is available read more...

Leave a comment

Contact Info

  • Crimson Publishers, LLC
  • 555 Madison Avenue, 5th floor
  •     New York, NY 10022, USA
  • +1 (929) 600-8049
  • +1 (929) 447-1137
  • info@crimsonpublishers.com
  • www.crimsonpublishers.com